| Literature DB >> 33776435 |
Zhengguo Qiu1, Qianhe Shen2, Chao Jiang3, Li Yao4, Xiaopeng Sun5, Jing Li6, Chongzhen Duan1, Rui Li1, Xiuli Li1, Subash C B Gopinath7,8, Periasamy Anbu9, Thangavel Lakshmipriya8, Xu Li10.
Abstract
BACKGROUND: Alzheimer's disease (AD) is a neurodegenerative chronic disorder that causes dementia and problems in thinking, cognitive impairment and behavioral changes. Amyloid-beta (Aβ) is a peptide involved in AD progression, and a high level of Aβ is highly correlated with severe AD. Identifying and quantifying Aβ levels helps in the early treatment of AD and reduces the factors associated with AD.Entities:
Keywords: amyloid-beta; antibody; aptamer; biomarker; nanomaterial
Mesh:
Substances:
Year: 2021 PMID: 33776435 PMCID: PMC7989959 DOI: 10.2147/IJN.S302396
Source DB: PubMed Journal: Int J Nanomedicine ISSN: 1176-9114
Figure 1Schematic illustration of AβO determination on a nanohorn-modified dielectrode. Three methods of AβO detection were compared with the probes of (i) Au-urchin antibody; (ii) Au-urchin antibody-aptamer; and (iii) dual probe of aptamer and antibody on Au urchin.
Figure 2Surface analysis by EDX. (A) AFM image of Au urchin; (B) surface of Au urchin-attached wafer; (C) FETEM image of Au urchin; (D) EDX analysis of Au urchin; (E) elemental composition of Au urchin. EDX results confirm the presence of carbon and gold on the immobilized surface.
Figure 3Surface morphology of the nanomaterial-modified electrode. (A) FESEM image of Au urchin; (B) EDX analysis of Au urchin; (C) FESEM image of nanohorn; Figure inset is at higher magnification. (D) EDX analysis of nanohorns; (E) FESEM image of Au-urchin antibody on nanohorns; (F) EDX analysis of Au-urchin antibody on nanohorns. EDX results confirm the presence of carbon and gold on the immobilized surfaces.
Figure 4Comparison of probe immobilization on nanohorn-modified electrodes. (A) Au urchin antibody immobilization on APTMS-nanohorn; (B) aptamer titration on Au-urchin-antibody attached electrode; (C) dual probe of antibody-aptamer immobilization on APTMS-nanohorn; Figure insets are diagrammatic. (D) Comparison of current changes with different probe immobilizations. The dual probe of the aptamer and antibody shows the highest current response.
Figure 5Comparison of detection of 1 nM AβO on (A) Au urchin antibody immobilized electrode; (B) antibody-aptamer immobilized electrode; (C) dual probe of antibody-aptamer immobilized electrode; Figure insets are diagrammatic. (D) Comparison of current changes of AβO detection with different probes. A dual probe with an aptamer and antibody shows the highest current response.
Figure 6Different concentrations of AβO by titration (0.01–100 pM) on (A) Antibody-aptamer immobilized electrode; (B) dual probe of antibody-aptamer immobilized electrode; (C) comparison of current changes with AβO titration, dual probe shows the highest current response with all AβO concentrations; (D) difference in current changes in AβO determination were plotted in an Excel sheet and used to calculate the detection limit. The detection limit was found to be 10 fM by both methods.
Comparing Detection of Aβ with Available Methods
| Sensor | Target | Probe | Detection limit | Linear range | Reference |
| Smart near infrared fluorescence | Aβ 1-42 | π-electron chain for Aβ -plaques | 0.027 µM | - | ( |
| EIS sensor | Aβ-40 | Aptamer | ~20 fM | 0.1 pg/mL-10 µg/mL | ( |
| Electrochemical sensor | Aβ 1-42 | Aptamer | 3.5x10−14 mol/L | 1x10−13 to 1x10−8 mol/L | ( |
| Electrochemical sensor | AβO | Aptamer-antibody | 100 pM | 0.5-30 nM | ( |
| Impedance sesnor | AβO | Cellular prion protein | 0.1 pM | 10−8 to 104 nM | ( |
| Amperometric sensor | Aβ | Aptamer | 0.002 pM | 0.1 pM-10 nM | ( |
| SERS | Aβ | Sialic acid | 1 pM | 1 pM-11.5 nM | ( |
| Colorimetric assay | AβO | PrP | 20 nM | 20-100 nM | ( |
| Fluorescent sensor | Aβ | CRANAD-2 | 38 nM | - | ( |
| Electrochemical sensor | AβO | Aptamer-antibody | 10 fM | 0.01-100 pM | This work |
Abbreviations: EIS, electrode-insulator-semiconductor sensor; FET, field effect transistor.
Figure 7Selective detection. (A) AβO was identified with C-1 (no AβO), C-2 (with nonimmune and complementary aptamers), and C-3 (with control protein). No significant changes were noted in any of the above three control experiments compared with the specific interaction(s) of AβO with its antibody and aptamer. (B) Spiking experiment. Different AβO concentrations (0.01, 0.1, 1 and 10 pM) in artificial CSF were dripped independently on dual probe-modified surfaces. CSF did not interfere with the interaction of AβO with its antibody and aptamer.